Review Article
Clinicopathological Significance of Heat Shock Protein (HSP) 27 Expression in Gastric Cancer: A Updated Meta-Analysis
Table 2
The odds ratio between HSP27 expression and clinicopathological feature of gastric cancer.
| Clinicopathological features | Heterogeneity | No. of studies | No. of patients | Pooled OR (95% CI) | PHet | I2 (%) | P value | Model used |
| HSP27 expression | GC vs AT | 5 | 173 | 6.25 (2.88, 13.57) | 0.008 | 71 | <0.00001 | Random | GC vs NT | 4 | 159 | 6.31 (1.10, 36.15) | <0.0001 | 86 | 0.04 | Random | Differentiation | PD vs HMD | 9 | 270 | 1.14 (0.52, 2.52) | 0.001 | 69 | 0.74 | Random | Gender | Male vs female | 6 | 231 | 0.95 (0.62, 1.48) | 0.71 | 0 | 0.83 | Fixed | Lymph node metastasis | N1-3 vs N0 | 7 | 289 | 1.44 (0.66, 3.16) | 0.004 | 69 | 0.36 | Random | Distant metastasis | M1 vs M0 | 3 | 96 | 0.64 (0.10, 4.09) | 0.09 | 58 | 0.64 | Random |
|
|
Abbreviations: GC, gastric cancer; AT, adjacent tissue; NT, normal tissue; PD, poor differentiation; HMD, high or moderate differentiation; random, random effect model; fixed, fixed effect model; OR, odds ratio; CI, conference interval.
|